SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 5 filers reported holding SIO GENE THERAPIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $151,050 | +208.3% | 347,242 | +100.0% | 0.00% | – |
| Q3 2022 | $49,000 | -22.2% | 173,621 | 0.0% | 0.00% | – |
| Q2 2022 | $63,000 | -43.8% | 173,621 | +3.9% | 0.00% | – |
| Q1 2022 | $112,000 | -44.8% | 167,121 | +6.3% | 0.00% | – |
| Q4 2021 | $203,000 | -15.1% | 157,200 | +42.9% | 0.00% | – |
| Q3 2021 | $239,000 | +10.6% | 110,000 | +39.1% | 0.00% | – |
| Q2 2021 | $216,000 | – | 79,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower View Wealth Management LLC | 11,645 | $1,348,000 | 1.02% |
| Cladis Investment Advisory, LLC | 552,000 | $155,000 | 0.20% |
| Rubric Capital Management LP | 7,000,000 | $1,960,000 | 0.10% |
| Newtyn Management, LLC | 1,500,000 | $420,000 | 0.09% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $1,656,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 146,500 | $41,000 | 0.06% |
| Clearline Capital LP | 392,691 | $110,000 | 0.01% |
| Hudson Bay Capital Management LP | 1,680,536 | $471,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 105,400 | $30,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 2,400 | $1,000 | 0.00% |